This grant funds research aimed at developing new information and strategies to improve detection efforts for identifying patients with AAT Deficiency. It encourages collaboration between two principal investigators to foster team-based approaches to detection research. Pharmaceutical, biotech, and industry applicants or collaborators are excluded from eligibility.
Applicants from pharmaceutical companies, biotechs, or industry are not eligible to apply or collaborate. Eligible applicants must be outside these sectors.
